Ew. Inscho et al., DIRECT ASSESSMENT OF RENAL MICROVASCULAR RESPONSES TO P2-PURINOCEPTORAGONISTS, American journal of physiology. Renal, fluid and electrolyte physiology, 43(4), 1998, pp. 718-727
Studies were performed to determine the responsiveness of rat juxtamed
ullary afferent arterioles to receptor-selective P2-purinoceptor agoni
sts. Experiments were performed in vitro using the blood perfused juxt
amedullary nephron technique, combined with videomicroscopy. Renal per
fusion pressure was set at 110 mmHg and held constant. Basal afferent
arteriolar diameter averaged 22.0 +/- 0.6 mu m (n = 69). Stimulation w
ith 0.1, 1.0, 10, and 100 mu M ATP (n = 10) elicited a concentration-d
ependent vasoconstriction averaging 8 +/- 2, 17 +/- 2, 21 +/- 4, and 2
3 +/- 5%, respectively. A nearly identical afferent arteriolar vasocon
striction was observed in response to the P2X-selective agonist beta,g
amma-methylene ATP (n = 10); however, another P2X agonist, alpha,beta-
methylene ATP, evoked marked receptor desensitization (n = 10). Vessel
diameter decreased by similar to 7 +/- 2, 16 +/- 2, 23 +/- 3, and 22
+/- 3%, respectively, over the same concentration range. The P2Y-selec
tive agonist, 2-methylthio-ATP, evoked only a modest vasoconstriction,
whereas UTP and adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S) red
uced afferent diameter markedly at concentrations >1.0 mu M. Afferent
arteriolar diameter decreased by 5 +/- 4, 31 +/- 8, and 72 +/- 8% duri
ng UTP administration (n = 7) at concentrations of 1.0, 10, and 100 mu
M, respectively. Similarly, ATP gamma S (n = 6) decreased afferent di
ameter by 16 +/- 2, 58 +/- 8, and 98 +/- 3%, respectively, over the sa
me concentration range. Nitric oxide synthesis inhibition with N-omega
-nitro-L-arginine did not significantly alter the afferent arteriolar
response to ATP but did potentiate ATP-mediated arcuate artery vasocon
striction. The following data suggest the presence of multiple P2 rece
ptors on juxtamedullary afferent arterioles and are consistent with cl
assification of those receptors as members of the P2X- and P2Y(2) (P2U
)-receptor subtypes.